Two new drugs prolong lives of renal cancer victims: studie


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/afp/20070110/hl_afp/ushealthcancerdrugs"><img src="http://d.yimg.com/us.yimg.com/p/afp/20070110/capt.sge.gzk13.100107232511.photo00.photo.default-512x327.jpg?x=130&y=82&sig=3sSzvpYlfL6dZWthd6F36w--" align="left" height="82" width="130" alt="A cancer patient checks her muscle tone during chemotherapy treatment at Cape Fear Valley Medical Center in Fayetteville, North Carolina, June 2003. Two new treatments doubled the life expectancy of people afflicted with advanced cases of the very common cancer of the kidney, said new studies published in the United States.(AFP/Getty Images/File/Chris Hondros)" border="0" /></a>AFP - Two new treatments doubled the life expectancy of people afflicted with advanced cases of the very common cancer of the kidney, said new studies published in the United States.</p><br clear="all"/>